Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,220 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07486921RecruitingPhase 2
Etrasimod to prevent pouchitis after ulcerative colitis surgery
This trial tests if etrasimod can prevent pouchitis, which is inflammation of the surgically created internal pouch, in people who have had their colon removed due to ulcerative colitis. If you are at high risk for pouchitis or have had only one episode, this study may help keep your pouch healthy.
New York, New YorkAges 18–65 - NCT07487363RecruitingPhase 1/Phase 2
TB-500 for heart health in stable artery disease
This study tests if TB-500 can improve blood markers of cardiovascular health in people with stable artery disease. It is an early-phase trial to see if the drug is safe and shows promise.
Shenzhen, GuangdongAges 40–75 - NCT07487376RecruitingPhase 1
A single-dose study of IBIO-600 in healthy overweight or obese adults
This trial tests a single dose of an experimental treatment called IBIO-600 to see if it's safe and how it works in overweight or obese adults. It's for people who are generally healthy and have a stable weight, without diabetes.
Bayswater, VictoriaAges 18–65 - NCT07488065RecruitingPhase 1
New drug for moderate to severe eczema
This trial tests a new injectable drug called SKB575 for people with moderate to severe atopic dermatitis (eczema). It aims to see how safe and effective the drug is, especially for those who haven't had success with strong creams or pills.
ShanghaiAges 18–70 - NCT07490587RecruitingPhase 2
Probiotic study for healthy infant growth and allergy prevention
This trial tests a probiotic supplement (Bifidobacterium animalis subsp. lactis XLTG11) to see if it helps infants grow better and have fewer allergies. It is for healthy babies up to 3 years old who are at higher risk for allergies.
Pudong, Shanghai MunicipalityAges birth–3 years - NCT07493265RecruitingPhase 2
Study of E2086 for adults with narcolepsy
This study tests a new drug called E2086 to see if it can help reduce daytime sleepiness and sudden muscle weakness in adults with narcolepsy. It involves two groups: people with cataplexy (type 1) and those without (type 2).
Santa Ana, CaliforniaAges 18 years+ - NCT07494214RecruitingPhase 1
Study on MDMA for pain relief in healthy people
This trial tests if a single dose of MDMA can reduce pain caused by heat or pressure in healthy volunteers. It aims to see if MDMA might help with certain types of pain that are hard to treat.
BaselAges 18–75 - NCT07495202RecruitingPhase 1
Monkeypox vaccine trial for healthy adults
This trial tests a new monkeypox vaccine to see if it's safe and works. It's for healthy adults who haven't had monkeypox or smallpox before.
Shenzhen, GuangdongAges 18–59 - NCT07495852RecruitingPhase 3
Implant for eye pressure in glaucoma or ocular hypertension
This trial tests a tiny implant that slowly releases medication inside the eye to lower pressure. It is for people with open-angle glaucoma or high eye pressure who have not had certain eye surgeries.
Dothan, AlabamaAges 18 years+ - NCT07496021Recruiting
Probiotic for early Alzheimer's: safety and memory benefits
This trial tests a new probiotic (Lactococcus lactis CKDB001) to see if it can slow memory loss in people with early Alzheimer's. It’s a 12-week study that requires a positive amyloid PET scan and allows mild to moderate symptoms.
Gyeonggi-doAges 55–85 - NCT07497698Recruiting
Saffron supplement for better sleep in adults
This study tests whether taking a saffron extract supplement can help improve sleep in middle-aged adults with mild to moderate sleep troubles. You would take a daily supplement for a few weeks and report how well you sleep.
Granada, GranadaAges 18–65 - NCT07497932Recruiting
Nutritional effects in heart surgery
This trial looks at whether adding a probiotic supplement before cardiovascular surgery can improve recovery. It studies the link between nutrition, gut health, and surgical outcomes.
New Taipei CityAges 50–80 - NCT07498712Recruiting
Studying a probiotic for better sleep
This trial tests if a probiotic called Lactobacillus reuteri can improve sleep quality. Researchers want to see if taking this 'good bacteria' helps people who have mild to moderate sleep troubles feel more rested.
Seoul, YeongdeungpoAges 19–65 - NCT07499440RecruitingPhase 2
Testing a new medicine, HB-1, for PTSD
This trial tests an experimental medicine, HB-1, as a potential treatment for PTSD. It is a 8-week study to see if the medicine is safe and if it reduces PTSD symptoms. You must have a stable medication routine and be willing to take the study pill daily.
Bruce, Australian Capital TerritoryAges 18–65 - NCT07499700RecruitingPhase 2/Phase 3
Study of BAT4406F injection for MCD and FSGS
This trial tests an injected drug called BAT4406F for people with Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS), two types of kidney diseases that cause swelling and high protein in urine. It aims to see if the drug can help patients who have responded well to steroid therapy in the past.
Beijing, Beijing MunicipalityAges 18–75 - NCT07500181RecruitingPhase 1
Testing the safety of a new antibiotic in healthy adults
This trial tests an investigational antibiotic called BAL2420 to see if it is safe and how the body processes it. Healthy volunteers are needed to help determine the right dose before it can be studied in people with infections.
GroningenAges 18–55 - NCT07500506RecruitingPhase 3
Safety of a fifth dose of the Lyme disease vaccine
This study is for people who have already received four doses of the Lyme vaccine (VLA15) in a previous study. It tests whether a fifth dose is safe and helps the body build more protection against Lyme disease.
Bangor, MaineAges 7 years+ - NCT07500649Recruiting
Study of SIRT6 activator for prefrail older men
This study tests a new compound (SIRT6 activator) to see if it can improve health in older men who are starting to feel a little frail. It involves skin samples and avoiding certain foods and medications.
Singapore, SingaporeAges 50–80 - NCT07501377Recruiting
Diet and brain health study for women in menopause with overweight
This trial tests whether a diet rich in fiber and plant compounds (polyphenols) can reduce brain inflammation in perimenopausal women who are overweight. If you're in early menopause and have some inflammation, this study may show how diet affects your brain health.
Leipzig, SaxonyAges 35–60 - NCT07502560RecruitingPhase 4
Shingles vaccine to prevent dementia in Finland
This study tests whether the shingles vaccine can reduce the risk of developing dementia in adults 76 and older living in Finland. You would get the vaccine and then researchers will follow your health records for up to several years to see if it protects your brain.
EspooAges 76 years+ - NCT07502508RecruitingPhase 2
Icovamenib for type 2 diabetes with Ozempic
This trial tests an investigational pill called icovamenib for people with type 2 diabetes who are already on Ozempic but still have high blood sugar. The goal is to see if adding icovamenib helps lower blood sugar more safely.
Birmingham, AlabamaAges 18–70 - NCT07503210RecruitingPhase 3
Study of a new medicine to maintain weight loss
This study tests an investigational medicine to help people who have lost weight keep it off. It's for adults without diabetes who haven't used similar weight-loss drugs before.
Anniston, AlabamaAges 18 years+ - NCT07504068Recruiting
Exercise and supplement for metabolic health in overweight adults
This trial tests whether a combination of physical exercise and a nutritional supplement can improve body composition, metabolism, and overall health in adults who are overweight and have early signs of metabolic problems. It may help you if you are looking for a non-drug approach to boost your health.
Valencia, ValenciaAges 50–65 - NCT07505745RecruitingPhase 2
A study on MOTS-c for improving insulin sensitivity
This trial tests an investigational peptide (MOTS-c) to see if it can improve how your body uses insulin. It's for adults with prediabetes and excess weight who are not yet on diabetes medications and can maintain a stable diet and activity level for 12 weeks.
Shenzhen, GuangdongAges 18–65
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,220 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.